The advertisement promotes IQIRIVO® as a treatment for primary biliary cholangitis (PBC), highlighting its use in combination with ursodeoxycholic acid (UDCA) or as a monotherapy for patients who cannot tolerate UDCA.
Creative Information
| CID: | fbd6abce-a148-4689-ab10-3ee17c8bbd42 |
| CRID: | 89_223513 |
| Domain: | avalere.com |
| Seat: | DInt |
| Size: | 728x90 |
| Bid: | $2.75 |
| Timestamp: | 12/10/2025, 5:52:47 PM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 12/10/2025, 6:01:52 PM | 6.69s | |
| adomain_analysis | success | 12/10/2025, 6:12:14 PM | 3.44s | |
| adomain_capture | success | 12/10/2025, 6:12:10 PM | 0.20s | |
| ad_render | success | 12/10/2025, 6:01:45 PM | 22.91s | |
| brand_mapping | success | 12/10/2025, 5:52:47 PM | 0.07s | |
Analysis Results
Ad Format: banner
Brands: Avalere
Sensitive:Pharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 728x90 | ||||||||||||||||||||||
| Data Transferred: | 1043.62 KB | ||||||||||||||||||||||
| Render Time: | 8.90 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 1043.70 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives

